Marion Flechtner‐Mors

2.4k total citations
46 papers, 1.3k citations indexed

About

Marion Flechtner‐Mors is a scholar working on Physiology, Public Health, Environmental and Occupational Health and Pharmacology. According to data from OpenAlex, Marion Flechtner‐Mors has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Physiology, 12 papers in Public Health, Environmental and Occupational Health and 10 papers in Pharmacology. Recurrent topics in Marion Flechtner‐Mors's work include Diet and metabolism studies (15 papers), Obesity, Physical Activity, Diet (11 papers) and Pharmacology and Obesity Treatment (10 papers). Marion Flechtner‐Mors is often cited by papers focused on Diet and metabolism studies (15 papers), Obesity, Physical Activity, Diet (11 papers) and Pharmacology and Obesity Treatment (10 papers). Marion Flechtner‐Mors collaborates with scholars based in Germany, United States and Austria. Marion Flechtner‐Mors's co-authors include H. Ditschuneit, Guido Adler, Timothy D. Johnson, Reinhard W. Holl, G. Adler, Christopher P. Jenkinson, Andreas Alt, Susanna Wiegand, Bernhard O. Boehm and Thomas Reinehr and has published in prestigious journals such as PLoS ONE, American Journal of Clinical Nutrition and ACS Applied Materials & Interfaces.

In The Last Decade

Marion Flechtner‐Mors

45 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marion Flechtner‐Mors Germany 20 539 438 310 197 170 46 1.3k
Basilio Moreno Spain 14 521 1.0× 407 0.9× 308 1.0× 134 0.7× 101 0.6× 27 1.2k
Mike Lean United Kingdom 19 383 0.7× 403 0.9× 214 0.7× 95 0.5× 161 0.9× 35 1.2k
Elizabeth Konz United States 4 664 1.2× 500 1.1× 247 0.8× 207 1.1× 306 1.8× 7 1.3k
MEJ Lean United Kingdom 16 607 1.1× 565 1.3× 428 1.4× 473 2.4× 239 1.4× 21 1.7k
Joi A. Gleason United States 9 1.2k 2.2× 695 1.6× 513 1.7× 172 0.9× 191 1.1× 14 1.7k
MEJ Lean United Kingdom 13 612 1.1× 297 0.7× 636 2.1× 485 2.5× 165 1.0× 32 1.4k
Teodora Handjieva‐Darlenska Denmark 23 1.2k 2.3× 809 1.8× 270 0.9× 103 0.5× 104 0.6× 51 1.9k
Tania Markovic Australia 24 909 1.7× 628 1.4× 431 1.4× 117 0.6× 178 1.0× 85 2.1k
Courtney Luecking United States 11 448 0.8× 218 0.5× 248 0.8× 104 0.5× 81 0.5× 21 969
Radhika V. Seimon Australia 22 1.2k 2.3× 372 0.8× 380 1.2× 109 0.6× 90 0.5× 55 1.8k

Countries citing papers authored by Marion Flechtner‐Mors

Since Specialization
Citations

This map shows the geographic impact of Marion Flechtner‐Mors's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion Flechtner‐Mors with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion Flechtner‐Mors more than expected).

Fields of papers citing papers by Marion Flechtner‐Mors

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion Flechtner‐Mors. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion Flechtner‐Mors. The network helps show where Marion Flechtner‐Mors may publish in the future.

Co-authorship network of co-authors of Marion Flechtner‐Mors

This figure shows the co-authorship network connecting the top 25 collaborators of Marion Flechtner‐Mors. A scholar is included among the top collaborators of Marion Flechtner‐Mors based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion Flechtner‐Mors. Marion Flechtner‐Mors is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mailänder, Volker, et al.. (2017). Sequence-Controlled Delivery of Peptides from Hierarchically Structured Nanomaterials. ACS Applied Materials & Interfaces. 9(4). 3885–3894. 20 indexed citations
3.
Schümann, Uwe, Christopher P. Jenkinson, Andreas Alt, et al.. (2017). Sympathetic nervous system activity and anti-lipolytic response to iv-glucose load in subcutaneous adipose tissue of obese and obese type 2 diabetic subjects. PLoS ONE. 12(3). e0173803–e0173803. 4 indexed citations
4.
Boettcher, Claudia, Axel Dost, Stefan A. Wudy, et al.. (2014). Accuracy of Blood Glucose Meters for Self-Monitoring Affects Glucose Control and Hypoglycemia Rate in Children and Adolescents with Type 1 Diabetes. Diabetes Technology & Therapeutics. 17(4). 275–282. 24 indexed citations
5.
Flechtner‐Mors, Marion, Suemeyra Oeztuerk, Mark Martin Haenle, et al.. (2014). Association of adiponectin with hepatic steatosis: a study of 1,349 subjects in a random population sample. BMC Research Notes. 7(1). 207–207. 19 indexed citations
6.
Flechtner‐Mors, Marion, Susanna Wiegand, Kurt Widhalm, et al.. (2013). Screening for Co-Morbidity in 65,397 Obese Pediatric Patients from Germany, Austria and Switzerland: Adherence to Guidelines Improved from the Year 2000 to 2010. Obesity Facts. 6(4). 360–368. 6 indexed citations
7.
Meißner, Thomas, Johannes Wolf, Mathilde Kersting, et al.. (2013). Carbohydrate intake in relation to BMI, HbA1c and lipid profile in children and adolescents with type 1 diabetes. Clinical Nutrition. 33(1). 75–78. 25 indexed citations
8.
Holl, Reinhard W., Michael Thamm, Rainer Stachow, et al.. (2011). Does obesity lead to a specific lipid disorder? Analysis from the German/Austrian/Swiss APV registry. International Journal of Pediatric Obesity. 6(S1). 53–58. 14 indexed citations
9.
Flechtner‐Mors, Marion, et al.. (2010). Enhanced weight loss with protein‐enriched meal replacements in subjects with the metabolic syndrome. Diabetes/Metabolism Research and Reviews. 26(5). 393–405. 53 indexed citations
10.
Jenkinson, Christopher P., Dawn K. Coletta, Marion Flechtner‐Mors, et al.. (2008). Association of Genetic Variation in ENPP1 With Obesity‐related Phenotypes. Obesity. 16(7). 1708–1713. 10 indexed citations
11.
Flechtner‐Mors, Marion, Christopher P. Jenkinson, Andreas Alt, G. Adler, & H. Ditschuneit. (2007). Metabolism in adipose tissue in response to citalopram and trimipramine treatment – An in situ microdialysis study. Journal of Psychiatric Research. 42(7). 578–586. 8 indexed citations
12.
Flechtner‐Mors, Marion, Christopher P. Jenkinson, Andreas Alt, et al.. (2004). Sympathetic Regulation of Glucose Uptake by the α1‐Adrenoceptor in Human Obesity. Obesity Research. 12(4). 612–620. 26 indexed citations
13.
Flechtner‐Mors, Marion, Hans Konrad Biesalski, Christopher P. Jenkinson, G. Adler, & H. Ditschuneit. (2004). Effects of moderate consumption of white wine on weight loss in overweight and obese subjects. International Journal of Obesity. 28(11). 1420–1426. 26 indexed citations
14.
Flechtner‐Mors, Marion, et al.. (2002). Lipoprotein responses to weight loss and weight maintenance in high-risk obese subjects. European Journal of Clinical Nutrition. 56(3). 264–270. 38 indexed citations
15.
Ditschuneit, H. & Marion Flechtner‐Mors. (2001). Value of Structured Meals for Weight Management: Risk Factors and Long‐Term Weight Maintenance. Obesity Research. 9(S11). 284S–289S. 72 indexed citations
16.
Flechtner‐Mors, Marion, Christopher P. Jenkinson, Andreas Alt, G. Adler, & H. Ditschuneit. (2001). Effects of acipimox on the lipolysis rate in subcutaneous adipose tissue of obese subjects. Diabetes/Metabolism Research and Reviews. 17(5). 387–390. 9 indexed citations
17.
Flechtner‐Mors, Marion, et al.. (2000). Metabolic and Weight Loss Effects of Long‐Term Dietary Intervention in Obese Patients: Four‐Year Results. Obesity Research. 8(5). 399–402. 202 indexed citations
18.
Flechtner‐Mors, Marion, H. Ditschuneit, Christopher P. Jenkinson, Andreas Alt, & G. Adler. (1999). Metformin inhibits catecholamine‐stimulated lipolysis in obese, hyperinsulinemic, hypertensive subjects in subcutaneous adipose tissue: an in situ microdialysis study. Diabetic Medicine. 16(12). 1000–1006. 24 indexed citations
19.
Flechtner‐Mors, Marion, et al.. (1999). Reduced epinephrine-stimulated lipolytic activity in male golden-mantled ground squirrel during hibernation: an in situ microdialysis study. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 123(3). 281–284. 7 indexed citations
20.
Ditschuneit, H., Marion Flechtner‐Mors, & G. Adler. (1996). The Effects of Dexfenfluramine on Weight Loss and Cardiovascular Risk Factors in Female Patients with Upper and Lower Body Obesity. European Journal of Cardiovascular Prevention & Rehabilitation. 3(4). 397–403. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Basilio Moreno Breakdown of academic impact, for papers by Mike Lean Breakdown of academic impact, for papers by Elizabeth Konz Breakdown of academic impact, for papers by MEJ Lean Breakdown of academic impact, for papers by Joi A. Gleason Breakdown of academic impact, for papers by MEJ Lean Breakdown of academic impact, for papers by Teodora Handjieva‐Darlenska Breakdown of academic impact, for papers by Tania Markovic Breakdown of academic impact, for papers by Courtney Luecking Breakdown of academic impact, for papers by Radhika V. Seimon
Rankless by CCL
2026